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Abstract
The cytotoxin-associated gene (Cag) pathogenicity island is a strain-specific constituent of
Helicobacter pylori (H. pylori) that augments cancer risk. CagA translocates into the cyto-
plasm where it stimulates cell signaling through the interaction with tyrosine kinase c-Met re-
ceptor, leading cellular proliferation. Identified as a potential gastric stem cell marker,
cluster-of-differentiation (CD) CD44 also acts as a co-receptor for c-Met, but whether it
plays a functional role in H. pylori-induced epithelial proliferation is unknown. We tested the
hypothesis that CD44 plays a functional role in H. pylori-induced epithelial cell proliferation.
To assay changes in gastric epithelial cell proliferation in relation to the direct interaction
with H. pylori, human- and mouse-derived gastric organoids were infected with the G27 H.
pylori strain or a mutant G27 strain bearing cagA deletion (ΔCagA::cat). Epithelial prolifera-
tion was quantified by EdU immunostaining. Phosphorylation of c-Met was analyzed by
immunoprecipitation followed byWestern blot analysis for expression of CD44 and CagA.
H. pylori infection of both mouse- and human-derived gastric organoids induced epithelial
proliferation that correlated with c-Met phosphorylation. CagA and CD44 co-immunoprecipi-
tated with phosphorylated c-Met. The formation of this complex did not occur in organoids
infected with ΔCagA::cat. Epithelial proliferation in response to H. pylori infection was lost in
infected organoids derived from CD44-deficient mouse stomachs. Human-derived fundic
gastric organoids exhibited an induction in proliferation when infected with H. pylori, that
was not seen in organoids pre-treated with a peptide inhibitor specific to CD44. In the well-
established Mongolian gerbil model of gastric cancer, animals treated with CD44 peptide in-
hibitor Pep1, resulted in the inhibition of H. pylori-induced proliferation and associated atro-
phic gastritis. The current study reports a unique approach to study H. pylori interaction with
the human gastric epithelium. Here, we show that CD44 plays a functional role in H. pylori-
induced epithelial cell proliferation.
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Author Summary
Chronic gastric inflammation, typically caused byHelicobacter pylori (H. pylori), is the
most consistent lesion leading to cancer. During a well-choreographed interaction be-
tween H. pylori and the host, the progression from chronic inflammation to cancer in-
volves gastric epithelial changes with evidence of hyperproliferation. Our knowledge of
H. pylori pathogenesis is predominantly based on data generated from gastric cancer cell
lines or animal models of inflammation. We report the development and use of a novel
model of primary human and mouse cultured gastric epithelial cells that are organized
into three-dimensional spheroid units containing a lumen, known as gastric organoids. To
assay changes in gastric epithelial cell proliferation in relation to the direct interaction
with H. pylori, human- and mouse-derived gastric organoids were infected with the bacte-
ria. Cluster-of-differentiation gene (CD44) is a transmembrane receptor responsible for
epithelial cell proliferation. We show that CD44 plays a functional role inH. pylori-in-
duced proliferation. In a Mongolian gerbil animal model of H. pylori-induced gastric can-
cer, we show that inhibiting CD44 blocks epithelial proliferation and subsequently cancer
progression in response to bacterial infection. Thus our study provides new insights into
the role of CD44 inH. pylori-induced hyperproliferation and progression of
gastric disease.
Introduction
The major cause of chronic inflammation in the stomach isHelicobacter pylori (H. pylori) [1],
and it is widely accepted that chronic inflammation is a trigger for the development of gastric
cancer [2]. The severity and localization of the inflammation that results fromH. pylori infec-
tion is believed to dictate the pathological consequence of disease. Individuals most at risk of
developing gastric cancer are those in whom the bacteria colonize the corpus (or fundus) of the
stomach, when acid secretion is impaired. The subsequent development of severe inflamma-
tion in the gastric fundus leads to atrophy of the acid-secreting parietal cells and subsequently
further hypochlorhydria, metaplasia and carcinoma [3,4,5]. Given that individuals most at risk
of developing gastric cancer are those in whom the bacteria colonize the corpus [3,4,5], the cur-
rent research is focused on the use of human- and mouse-derived fundic gastric epithelium,
cultured as 3-dimensional structures called gastrointestinal organoids, for the study of H.
pylori pathogenesis.
The cytotoxin-associated gene (cag) pathogenicity island is a strain-specific constituent of
H. pylori that augments cancer risk [6]. The cag pathogenicity island encodes a type IV secre-
tion system that is a multimolecular complex that mediates the translocation of bacterial fac-
tors into the host cell [6,7]. Upon delivery into the host cells by the type IV cag secretion
system, CagA translocates into the host cell cytoplasm where it can stimulate cell signaling
through interaction with several host proteins [6,8,9] including the tyrosine kinase c-Met re-
ceptor [10,11,12]. CagA exerts effects within host cells that mediate carcinogenesis, including
aberrant activation of phosphatidylinositol 3-phosphate kinase (PI3K) and β catenin, disrup-
tion of apical-junctional complexes, and loss of cellular polarity [13,14,15].
Another host molecule that may influence carcinogenesis in conjunction withH. pylori and
CagA is the cluster-of-differentiation (CD) CD44 cell surface receptor for hyaluronate [16].
CD44 is a cell surface adhesion molecule, expressed on a variety of cells including gastric epi-
thelial cells, that has recently been identified as a gastric cancer stem cell marker, whereby cells
expressing CD44 have been shown to possess the properties of gastric cancer stem cells [17].
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CD44 variant isoforms, in particular CD44v6, was identified as a marker for invasive intramu-
cosal carcinoma and premalignant lesions [18]. Suzuki et al. [19] demonstrated that CagA CM
motifs interact with Met leading to sustained PI3K-AKT signaling in response toH. pylori re-
sulting in cellular proliferation. Notably, the isoform containing exon v6 (CD44v6) acts as the
coreceptor for c-Met, most probably, through binding of c-Met ligand hepatocyte growth fac-
tor (HGF) [20,21]. The coreceptor function of CD44v6 for c-Met is of particular interest given
that studies pinpoint CD44v6 as a marker of early invasive intramucosal gastric carcinoma
[18]. Whether CD44v6 acts as a coreceptor for the function of c-Met in response toH. pylori
infection is unknown.
Our current knowledge ofH. pylori pathogenesis is largely based on data generated from
gastric cancer cell lines or in vivo animal models of inflammation. Thus, despite extensive evi-
dence demonstrating thatH. pylori induces gastric epithelial changes, the direct impact of the
bacterium on the normal epithelium is unclear. Culture of primary human- and mouse-derived
gastric stem cells as 3-dimensional structures called gastrointestinal organoids are a rapidly
emerging approach to study gastrointestinal development, physiology, stem cell biology and
disease [22,23,24,25,26,27,28,29]. Troy-positive cells are expressed at the corpus gland base in a
subset of differentiated chief cells [23]. Stange et al. [23] demonstrate that Troy-positive chief
cells may be used to generate long-lived gastric organoids, but in vitro these cultures are differ-
entiated toward the mucus-producing cell lineages of the neck and pit regions. The Troy-de-
rived organoids are distinct from the cultures that we derive from whole dissociated glands
reported here such that we have devised a method to maintain all the major cell lineages of the
fundus [22,28]. In this investigation, we used our method of mouse-derived gastric organoid
cultures as an approach to assay changes in gastric epithelial cell proliferation in relation to the
direct interaction with H. pylori [22,24,29]. To study the functional role of CD44 in the context
of human epithelial tissue, we developed a protocol for culturing human-derived gastric orga-
noids. We developed cultures of human-derived fundic gastric organoids independent of the
recent report by the Clevers group demonstrating the establishment of a similar culture model
for the study ofH. pylori pathogenesis [25]. Despite the extensive use of these culture systems
for the study of stem cell biology and gastrointestinal development [22,23,24,25,26,27,29], the
degree to which these cultures reflect the physiology of native tissue has been reported by our
laboratory alone [28]. Here we extend our current knowledge ofH. pylori pathogenesis by iden-
tifying the signaling mechanism by which bacterial infection induces proliferation in the gastric
epithelium. While it is known that c-Met is an important CD44 partner in proliferation, this is
the first report that this association occurs in response to H. pylori infection. We find that
CD44 plays a functional role in H. pylori-induced proliferation both in vitro and in vivo.
Results
CD44 mediates H. pylori-induced proliferation
To determine if CD44 plays a functional role in H. pylori-induced proliferation, C57BL/6 (BL/
6) control and CD44 deficient mice were infected with mouse adapted LSH100 H. pylori strain
for 4 weeks. The LSH100 mouse-adapted strain [30] is a descendant of the clinical isolate G27
[31]. We chose the LSH100 H. pylori to study the mechanism of bacterial-induced proliferation
in vivo because this particular strain efficiently expresses virulence factor CagA [14,31,32,33].
The proliferating cells were measured by BrdU incorporation (Fig. 1). There was a significant
increase of BrdU positive cells per gland in H. pylori LSH100 strain infected mice (6.23 + 0.53
BrdU+ cells/gland, Fig. 1B, E) compared to Brucella broth control mice (3.64 + 0.04 BrdU+
cells/gland, Fig. 1A, E). Infection of BL/6 mice with LSH100 strain bearing a CagA deletion
(ΔCagA) lacked the significant increase in proliferation (3.68 + 0.46 BrdU+ cells/gland,
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Fig 1. Epithelial proliferation in response to H. pylori infection of C57BL/6 (BL/6) and CD44 deficient (CD44KO) mice. Stomach sections collected
from (A) uninfected BL/6 control, (B) H. pylori infected BL/6, (C) ΔCagAH. pylori strain infected BL/6, and (D) uninfected and (E) H. pylori infected CD44KO
mice were immunostained for BrdU incorporation (blue nuclei). (F) Quantification of BrdU+ cells/gland in each group. *P<0.05 compared to controls, n = 6
mice per group.
doi:10.1371/journal.ppat.1004663.g001
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Fig. 1C, E). Importantly, CD44 deficient mice infected withH. pylori did not exhibit an increase
in proliferation (2.09 + 0.11 BrdU+ cells/gland, Fig. 1D, E) when compared to the Brucella
broth uninfected control CD44KOmouse group (2.10 + 0.29 BrdU+ cells/gland, Fig. 1E).
These data show that CD44 mediates CagA dependentH. pylori-induced proliferation.
H. pylori injection and viability in gastric organoids
To identify the direct impact of H. pylori on the host gastric epithelium, we employed the use
of a mouse-derived gastric organoid culture system. We have previously described a system for
culturing gastric organoids derived from mouse fundic tissue, in which the fundic organoids
are embedded in Matrigel, provided gastric organoid growth media, and co-cultured in trans-
well plates with immortalized stomach mesenchymal cells (ISMCs) [22,28]. Organoids were
microinjected withH. pylori strain G27. H. pylori strain G27, originally isolated from an endos-
copy patient from Grosseto Hospital (Tuscany, Italy) [31], is readily transformable and there-
fore amenable to gene disruption [34]. Of relevance to the current study, strain G27 efficiently
delivers the translocated virulence factor CagA to cells in culture [14,31,32,33]. Therefore, we
chose G27 to study the mechanism of H. pylori-induced proliferation using a strain that effi-
ciently expresses virulence factor CagA. Organoids were microinjected withH. pylori G27
strain (Fig. 2A), and bacterial adhesion was confirmed by Warthin-Starry stain (Fig. 2C, D)
and culture (Fig. 2E). Quantitative cultures showed a significant increase in the bacteria cul-
tured from organoids infected for 7 days compared to 24 hours and thus confirming bacterial
viability within the cultures (Fig. 2E). Therefore, the fundic organoids provided a method by
which bacterial-host cell interactions may be studied in the context of an intact normal gastric
epithelium in vitro.
CD44 mediates H. pylori-induced epithelial proliferation in mouse-
derived fundic gastric organoids (mFGOs)
When the mFGOs were infected with H. pylori G27 strain, we observed a significant increase
in epithelial cell proliferation in response to bacterial infection compared to the uninfected
controls (Fig. 3A, B). The proliferative response toH. pylori was significantly blocked when
organoids were pretreated with the c-Met inhibitor (c-MetI PF04217903 mesylate) (Fig. 3A, B).
Organoids infected with the G27 H. pylori strain that expressed a deletion of CagA (ΔCagA)
did not differ from the controls with regards to proliferation (Fig. 3A, B). These data show that
H. pylori-induced proliferation is mediated by activation of c-Met signaling as previously re-
ported [19]. Therefore, to advance this current knowledge, we examined whether c-Met was as-
sociated with CD44. Lysates were prepared from uninfected organoids and organoids infected
with either H. pylori (G27 strain) or ΔCagA and immunoprecipitated using an anti-c-Met anti-
body. Immunoprecipitates analyzed by Western blot using an anti-phosphotyrosine antibody
showed an increase in phosphorylated c-Met in response toH. pylori (Fig. 3C). Consistent with
published studies CagA coimmunoprecipitated with c-Met [19]. CD44 also coimmunoprecipi-
tated with c-Met. C-Met is an important partner with CD44 in proliferation, but this is the first
time that it has been reported that this association occurs in response toH. pylori infection.
There is evidence suggesting CD44 binds to hepatocyte growth factor (HGF) and acts as a co-
receptor by presenting HGF to c-Met and subsequently activating Met signaling [20,21]
(Fig. 3D). In response to H. pylori infection, we show for the first time, HGF also coimmuno-
precipitated with c-Met, and HGF expression was significantly upregulated in response to bac-
terial infection (Fig. 3C). Collectively, these data suggest that H. pylori induces the proliferation
of the gastric epithelium by promoting an association between CagA, Met and CD44.
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Fig 2. H. pylori microinjection and colonization of mFGOs.Organoids were microinjected withH. pylori
shown are mFGOs (A) before and (B) after injection. Arrow indicates injection needle. ‘Cloud’ of H. pylori
observed after injection is shown. Twenty-four hours after luminal microinjection, H. pylori (HP) attach to the
luminal surface demonstrated byWarthin-Starry stain of (C) control and (D) HP infected organoids. (E)
Quantitative cultures of HP of control and HP infected organoids. *P<0.05 compared to bacterial numbers at
day 1 after infection.
doi:10.1371/journal.ppat.1004663.g002
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Fig 3. Changes in proliferation inH. pylori infected mFGOs. (A) Immunofluorescence of EdU+ cells in control (CON), H. pylori (HP) and HP ΔCagA
infected and HP infected fundic organoids pretreated with c-Met inhibitor (c-MetI+HP). (B) Quantification of EdU+ cells/total cells. *P<0.05 compared to CON
group, n = 6 individual organoid preps per group. (C) Protein lysates were prepared frommFGOs that were uninfected (CON), HP or ΔcagA infected for 24
hours. Lysates were immunoprecipitated using an anti-c-Met antibody and immunoblotted for TyrP, c-Met, CagA, CD44 and HGF. (D) Proposed model of the
CD44 co-receptor function in response to H. pylori. (E) Immunofluorescence of EdU+ cells in CON, and HP infected organoids derived from CD44KOmouse
Helicobacter pylori-induced Epithelial Cell Proliferation
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To test the functional role of CD44 in mouse-derived gastric organoids, we cultured orga-
noids derived from mice that lacked the gene for CD44 (CD44KO). Organoids derived from
the stomachs of CD44 deficient (CD44KO) mice did not proliferate in response to H. pylori in-
fection (Fig. 3E). CD44KOmouse-derived organoids proliferated in response to a Wnt agonist,
and thus showing that this lack of response was specific toH. pylori (Fig. 3E). To determine if
CD44 was required for c-Met phosphorylation, lysates from uninfected control, H. pylori in-
fected and ΔCagA infected organoids derived from stomachs of CD44-deficient mice were col-
lected. In H. pylori infected CD44-deficient organoids c-Met was present but not
phosphorylated (Fig. 3F). Importantly, in the absence of CD44, CagA co-immunoprecipitated
with c-Met and is thus likely to form a complex with this receptor (Fig. 3F). In the absence of
CD44, HGF was not detected in the c-Met immunoprecipitated protein complex (Fig. 3F). Col-
lectively, these data further show that both CD44 and c-Met play a functional role in CagA de-
pendent H. pylori-induced epithelial cell proliferation in mouse-derived fundic
gastric organoids.
H. pylori infection triggers an epithelial-to-mesenchymal transition in
gastric organoids
In addition to increased epithelial cell proliferation, we observed striking morphological
changes in response toH. pylori infection that were consistent with epithelial-to-mesenchymal
transition (EMT) (Fig. 4). In uninfected control (CON) mouse-derived fundic gastric orga-
noids, we observed clear membrane-expressed E-cadherin (Fig. 4A). However, in theH. pylori
G27 strain infected organoids there was a disruption in membrane-expressed E-cadherin and
transition of the spheroid morphology to a cell monolayer was observed (Fig. 4B). In control
mouse-derived fundic gastric organoids infected with the ΔcagA strain, we also observed clear
membrane-expressed E-cadherin (Fig. 4C). EMT was also documented by increased expression
of markers that included alpha smooth muscle actin (αSMA), SNAIL2, TWIST1, N-cadherin
and Zeb1 (Fig. 4D). Organoids derived from the stomachs of CD44KOmice were also microin-
jected with Brucella broth (uninfected control), H. pylori G27 strain or H. pylori ΔcagA strain.
In all three groups membrane-expressed E-cadherin was observed (Fig. 4E). In addition
changes in gene expression of αSMA, SNAIL2, TWIST1, N-cadherin and Zeb1 was not ob-
served in infected CD44KO mouse-derived organoids (Fig. 4F). These data show that H. pylori
induces an EMT phenotype in the mouse-derived fundic gastric organoids and that this re-
sponse may be mediated by CD44.
Development and characterization of human fundic gastric organoids
(hFGOs)
To identify the role of CD44 as a mediator of H. pylori-induced proliferation in human epithe-
lium, we developed the human-derived fundic gastric organoids (hFGOs). Gastric glands were
enzymatically dissociated from the human fundic tissue embedded in Matrigel, provided gas-
tric organoid growth media and cultured to form hFGOs epithelial spheres over 7 days
(Fig. 5A). These 3 dimensional epithelial spheres contained markers specific for the fundic epi-
thelium, including H+,K+ ATPase (HK), Muc5ac, and Muc6, but do not contain gastrin, a
marker for the antral region of the stomach (Fig. 5B). Flow cytometric analysis showed that the
fundus. Quantification of EdU+ cells in CON, HP and or ΔCagA infected andWnt agaonist-treated (Wnt) organoids derived from CD44KOmouse fundus.
*P<0.05 compared to CON group, n = 3 individual organoid preps per group. (F) Protein lysates were prepared frommFGOs derived from CD44-deficient
mice that were uninfected (CON), HP or ΔCagA infected for 24 hours. Lysates were immunoprecipitated using an anti-c-Met antibody and immunoblotted for
TyrP, c-Met, CagA, CD44 and HGF.
doi:10.1371/journal.ppat.1004663.g003
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Fig 4. H. pylori-induced epithelial-to-mesenchymal transition (EMT). Immunofluorescence of EdU (red) and E-cadherin (green) using (A) uninfected
control (CON), (B) H. pylori (HP) or (C) ΔCagA infected mFGOs. (D) EMT marker (αSMA, SNAIL, TWIST, N-cadherin and Zeb) expression measured by
qRT-PCR using RNA isolated frommFGOs uninfected (control), H. pylori (HP) or ΔCagA infected. *P<0.05 compared to CON group, n = 4 individual
experiments/group. (E) Immunofluorescence of EdU (red) and E-cadherin (green) using uninfected control (CON), H. pylori (HP) and ΔCagA infected
mFGOs derived from stomachs of CD44-deficient mice. (F) (D) EMT marker (αSMA, SNAIL, TWIST, N-cadherin and Zeb) expression measured by qRT-
PCR using RNA isolated frommFGOs derived from CD44-deficient mouse stomachs uninfected (control), H. pylori (HP) or ΔCagA infected.
doi:10.1371/journal.ppat.1004663.g004
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Fig 5. Development and characterization of hFGOs. (A) Growth of human fundic glands into 3-dimensional epithelial spheres at day 1 and day 7. (B) The
hFGOs express markers normally found in human fundus including H+/K+ ATPase (HK), Muc5ac, and Muc6, but lack expression of the antral specific marker
gastrin. (C) Flow cytometric analysis of lineage markers for human fundus including UEAI, GSII, pepsinogen C (PgC), Chromogranin A (ChgA), and H+/K+
ATPase (HK). (D) Quantification of flow cytometric data shown in (C). Warthin-Starry staining on (E) uninfected control and (F) H. pylori injected hFGOs.
doi:10.1371/journal.ppat.1004663.g005
Helicobacter pylori-induced Epithelial Cell Proliferation
PLOS Pathogens | DOI:10.1371/journal.ppat.1004663 February 6, 2015 10 / 24
majority of cells in the human organoids were positive for the marker for parietal cells, H+,K+
ATPase, as would be expected in oxyntic glands in the human stomach (Fig. 5C). Quantifica-
tion of the flow cytometry histograms revealed that the hFGOs were comprised of approxi-
mately 5% UEAI+ cells (surface mucous pit cells), 15% GSII+ cells (mucous neck cells), 12%
pepsinogen C (PgC)+ cells (chief cells), 7% chromogranin A+ cells (ChgA endocrine cells) and
60% H+,K+ ATPase+ cells (HK, parietal cells) (Fig. 5D). As detailed for the mouse-derived fun-
dic gastric organoids, hFGOs were microinjected withH. pylori G27 strain and bacterial adhe-
sion was confirmed by Warthin-Starry stain (Fig. 5E, F). Therefore, the hFGOs provided a
method by which bacterial-host cell interactions were studied in the context of an intact nor-
mal human gastric epithelium in vitro.
CD44 mediates H. pylori-induced proliferation in hFGOs
To determine if the co-receptor role of CD44 and c-Met was intact in human tissue, hFGOs
were infected withH. pylori G27 strain. Compared to the control treated (CON) hFGOs, infec-
tion withH. pylori triggered a significant induction in proliferating cells that was not seen in
organoids injected with the ΔCagA mutant strain (Fig. 6A, B). Consistent with the response ob-
served in the mouse-derived organoids, the proliferative response to H. pylori was significantly
blocked when hFGOs were pretreated with the c-Met inhibitor (c-MetI PF04217903 mesylate)
(Fig. 6A, B). As detailed for the mouse-derived fundic gastric organoids, lysates were prepared
from uninfected and hFGOs infected with either H. pylori (G27 strain) or ΔCagA and immu-
noprecipitated using an anti-c-Met antibody. Immunoprecipitates analyzed by western blot
using an anti-phosphotyrosine antibody showed an increase in phosphorylated c-Met in re-
sponse toH. pylori (Fig. 6C). CagA, CD44 and HGF co-immunoprecipitated with c-Met. It is
known that c-Met is an important partner for CD44 in proliferation, but this is the first report
of the CD44/c-Met association occuring in response to H. pylori infection of the human
gastric epithelium.
To test the function of CD44v6 in hFGOs, we used a neutralizing antibody that specifically
targets human CD44v6. We found H. pylori-induced proliferation was blocked in hFGOs pre-
treated with the CD44v6 neutralizing antibody for one hour prior toH. pylori injection
(Fig. 6D, E). Treating hFGOs with the CD44v6 neutralizing antibody alone did not significant-
ly change the baseline of proliferation seen in the control hFGOs (Fig. 6D, E). Consistent with
data shown in Fig. 6C, immunoprecipitates analyzed by western blot showed an increase in
phosphorylated c-Met in response toH. pylori and CagA, CD44 and HGF co-immunoprecipi-
tated with c-Met (Fig. 6F). Interestingly, inhibition of CD44 binding to hyaluronic acid using
the CD44v6 peptide inhibited the co-immunoprecipitation of CD44 and HGF with c-Met
(Fig. 6F). These data indicate that CD44v6 plays a functional role inH. pylori-induced prolifer-
ation in hFGOs, and that c-Met may collaborate with CD44 in this proliferative response to H.
pylori infection in human tissue.
CD44 signaling mediates H. pylori-induced atrophic gastritis and
hyperproliferation in the Mongolian gerbil model of gastric cancer
We next investigated the role of CD44 in cancer progression using a well-established Mongo-
lian gerbil model of gastric cancer [35,36]. We administered an inhibitory peptide, Pep1, that
prevents binding of CD44 ligand hyaluronic acid (HA), thus blocking CD44 downstream sig-
naling. Gerbils were infected with H. pylori strain 7.13, an in vivo adapted strain originally iso-
lated from a gastric ulcer [37] and reported to reproducibly induce gastric cancer in Mongolian
gerbils [13,37]. We found that gerbils infected with H. pylori strain 7.13, developed atrophic
gastritis (Fig. 7B), as documented by neutrophil (Fig. 7E) and lymphocyte (Fig. 7F) infiltration,
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Fig 6. Changes in proliferation inH. pylori infected hFGOs. (A) Immunofluorescence of EdU+ cells in control (CON), H. pylori (HP) and HP ΔCagA
infected and HP infected fundic organoids pretreated with c-Met inhibitor (c-MetI+HP). (B) Quantification of EdU+ cells/total cells. *P<0.05 compared to CON
group, n = 6 individual organoid preps per group. (C) Protein lysates were prepared from hFGOs that were uninfected (CON), HP or ΔcagA infected for 24
hours. Lysates were immunoprecipitated using an anti-c-Met antibody and immunoblotted for TyrP, c-Met, CagA and CD44. (D) Immunofluorescence of EdU
+ cells in control (CON), H. pylori (HP) infected, CD44v6 neutralizing antibody treated (CD44v6) and HP infected pretreated with CD44v6 neutralizing
Helicobacter pylori-induced Epithelial Cell Proliferation
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development of lymphoid follicles (Fig. 7G) and atrophy (Fig. 7H), 6 weeks of infection, com-
pared to control (Brucella broth administered) gerbils (Fig. 7A, E-H). Gerbils that received
Pep1 injections three times a week for the duration of the 6 week infection withH. pylori, did
not exhibit the development of atrophic gastritis (Fig. 7D, E-H), compared to the gerbils who
received H. pylori and the scrambled control peptide (cPep1) (Fig. 7C, E-H).
Our studies show that CD44 plays a functional role in H. pylori-induced proliferation of
mouse and human epithelial tissues in vitro. Thus, we next examined the proliferative state in
response toH. pylori and Pep1 treatment in the Mongolian gerbils in vivo. Within 6 weeks of
infection with H. pylori (7.13) there was a significant induction in the number of proliferating
cells in the gastric epithelium (Fig. 8B, E) when compared to Brucella broth controls (Fig. 8A,
E). To determine if CD44 signaling was required for thisH. pylori induced proliferative re-
sponse, we treated theH. pylori infected gerbils three times a week with Pep1, and found that
the induction in proliferation was blocked (Fig. 8C, E). The gerbils infected withH. pylori and
treated with the scrambled control peptide (cPep1) exhibited the expected induction in prolif-
eration (Fig. 8D, E). Collectively, these data show that CD44 signaling mediates H. pylori-in-
duced atrophic gastritis and hyperproliferation in the Mongolian gerbil model of
gastric cancer.
Discussion
Prolonged cell proliferation in the gastric mucosa is a precursor to the progression from chron-
ic inflammation to gastric cancer in response toH. pylori infection [2]. However, the mecha-
nism by which H. pylori induces epithelial cell proliferation is not well defined. Here we report
the culture of primary human- and mouse-derived gastric epithelial cells as 3-dimensional
structures called gastrointestinal organoids for the study of H. pylori pathogenesis. We utilized
mouse-derived fundic gastric organoids (mFGOs), and for the first time we demonstrated that
CD44 and c-Met form a complex with virulence factor CagA in response toH. pylori infection.
To determine if this mechanism was present in human gastric epithelium, we developed a
novel protocol for the culture of differentiated human-derived fundic gastric organoids in cul-
ture (hFGOs). In the hFGOs, we found that inhibiting CD44 splice variant 6, a specific marker
for early invasive carcinoma [38], blockedH. pylori-induced proliferation. As in the mouse
organoids, H. pylori infection triggered the formation of a complex containing CD44, c-Met,
and CagA in the hFGOs. In addition, in the well-established Mongolian gerbil model of gastric
cancer, animals treated with CD44 peptide inhibitor Pep1, resulted in the inhibition of H. pylo-
ri-induced proliferation and associated atrophic gastritis.
Our experiments report for the first time that CD44 acts as a mediator of H. pylori-induced
proliferation both in vitro and in vivo. In vivo, we observed that CD44 regulates baseline prolif-
eration whereby, as previously reported [39], basal rate of proliferation was approximately half
that of control mice. However,H. pylori infection did not induce epithelial cell proliferation
within the CD44KOmice, suggesting a functional role of CD44 as a mediator of bacterial-in-
duced proliferation. Consistent with previous findings in gastric cancer cell lines [10], we also
report that the proliferative response to H. pylori was CagA- and c-Met-dependent within the
gastric epithelium. Western blot analysis using lysates collected fromH. pylori infected mFGOs
and hFGOs also showed that CagA coimmunoprecipitates with c-Met, as previously shown in
antibody (CD44v6+HP) hFGOs. (E) Quantification of EdU+ve cells/total cells. *P<0.05 compared to CON group, #P<0.05 compared to HP infected group, n
= 4 individual organoid preps per group. (F) Protein lysates were prepared from hFGOs that were uninfected (CON), H. pylori (HP) infected, CD44v6
neutralizing antibody treated (CD44v6) and HP infected pretreated with CD44v6 neutralizing antibody (CD44v6+HP). Lysates were immunoprecipitated
using an anti-c-Met antibody and immunoblotted for TyrP, c-Met, CagA and CD44.
doi:10.1371/journal.ppat.1004663.g006
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Fig 7. Inhibition of CD44 blocks the development of atrophic gastritis inH. pylori infected Mongolian gerbils.Mongolian gerbils were administered (A)
Brucella broth (control), (B) H. pylori strain 7.13 alone, and in combination with either a (C) control peptide (cPep1), or (D) peptide targeting CD44 (Pep1).
Gerbils were sacrificed after 6 weeks infection and H&E’s were scored using the updated Sydney classification for (E) neutrophil infiltration, (F) lymphocyte
infiltration, (G) lymphoid follicles, and (H) atrophy.
doi:10.1371/journal.ppat.1004663.g007
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Fig 8. Epithelial proliferation in response to H. pylori infection in Mongolian gerbils. Stomach sections collected fromMongolian gerbils administered
(A) Brucella broth (control), (B) H. pylori strain 7.13 alone, and in combination with either a (C) control peptide (cPep1), or (D) peptide targeting CD44 (Pep1)
were immunostained for BrdU incorporation (blue nuclei). (E) Quantification of BrdU+ cells/gland in each group. *P<0.05 compared to controls, n = 6 gerbils
per group.
doi:10.1371/journal.ppat.1004663.g008
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human gastric cancer cells [19]. Although we report thatH. pylori-induced proliferation was
dependent on CD44 expression and signaling, the CagA/c-Met association was also observed
in the absence of CD44 expression and signaling. Suzuki et al. [19] demonstrated that CagA
CMmotifs interact with Met leading to sustained PI3K-AKT signaling in response toH. pylori,
leading to β-catenin activation and cellular proliferation. We advance our understanding of
H. pylori-induced epithelial cell proliferation by demonstrating that CD44 acts as a coreceptor
for c-Met in response to bacterial infection. The isoform containing exon v6 (CD44v6) acts as
the coreceptor for c-Met in tumor cell lines [20,21]. The coreceptor function of CD44v6 for
c-Met is of particular interest given that studies pinpoint CD44v6 as a marker of early invasive
intramucosal gastric carcinoma [18]. Whether CD44v6 acted as a coreceptor for the function
of c-Met in response toH. pylori infection was unknown. However, we found thatH. pylori-in-
duced proliferation was blocked in hFGOs pre-treated with the CD44v6 neutralizing antibody,
and thus indicating that CD44v6 plays a functional role inH. pylori-induced proliferation in
the human gastric epithelium.
Our data suggest a coreceptor function of CD44 for c-Met in response toH. pylori infection.
The coreceptor function of CD44v6 for c-Met is shown to be dependent on HGF binding [20].
Indeed, we find that in the absence of CD44 expression and signaling HGF does not coimmu-
noprecipiate with c-Met andH. pylori fails to induce c-Met phosphorylation. In support of our
findings, HGF binding to c-MET results in receptor homodimerization and phosphorylation
of two tyrosine residues (Y1234 and Y1235) located within the catalytic loop of the tyrosine ki-
nase domain [40], and subsequent, phosporylation of tyrosines 1349 and 1356 in the carboxy-
terminal tail [41]. When these tyrosines become phosphorylated, they recruit signaling effec-
tors that includes phosphatidylinositol 3-kinase (PI3K). When Y1313 is phosphorylated, it
binds and activates PI3K, which promotes cell viability, motility and proliferation [42]. The ex-
tracellular domain of CD44v6 is necessary for c-Met activation, and this is dependent on HGF
binding [20]. Indeed in the mFGOs, in response to H. pylori infection, HGF also coimmuno-
precipitated with c-Met. The collaboration between c-Met and CD44v6 contributes to another
bacterial infection, for example the invasion of Listeria monocytogenes into target cells [43].
Based on evidence demonstrating a functional role of CD44 in bacterial infection [43] includ-
ingH. pylori infection, we conclude that the activation of c-Met is not only dependent on bind-
ing of H. pylori but in addition requires adhesion molecule CD44v6 as a co-receptor. In
addition, although the coreceptor function of CD44v6 for c-Met is shown to be dependent on
HGF binding, we show here for the first time that this signaling pathway mediates H. pylori-in-
duced epithelial cell proliferation.
In the well-established Mongolian gerbil model of gastric cancer [35,36], animals treated
with CD44 peptide inhibitor Pep1, resulted in the inhibition ofH. pylori-induced proliferation
and associated atrophic gastritis. Consistent with previous findings, infection with H. pylori for
6 weeks induced a significant inflammatory response, accompanied with the development of
atrophic gastritis and metaplasia [35,44]. Using Pep1, a peptide that blocks the interaction be-
tween hyaluronic acid and CD44, we found that H. pylori-induced atrophic gastritis was inhib-
ited. Importantly, infected gerbils that received Pep1 exhibited a significant reduction in
actively proliferating cells. In support of our studies, a previous report by Khurana et al. [39]
found that CD44 is a key coordinator of cell proliferation in a model of chemically-induced pa-
rietal cell atrophy, through downstream activation of STAT3. These findings strongly suggest
that future therapeutic targets could include CD44 inhibition, to prevent H. pylori-induced
hyperproliferation and cancer progression.
Our knowledge of H. pylori pathogenesis is predominantly based on data generated from
gastric cancer cell lines or in vivo animal models of inflammation. Thus, limitation in acquiring
such knowledge has been attributed to the inability to evaluate molecular mechanisms of
Helicobacter pylori-induced Epithelial Cell Proliferation
PLOS Pathogens | DOI:10.1371/journal.ppat.1004663 February 6, 2015 16 / 24
bacterial and host cell interactions in a setting of a sustained gastric epithelial cell diversity and
polarity. Our current work reports the development and use of a model of primary human and
mouse cultured gastric epithelial cells. These models recapitulate key features of the gastric en-
vironment including the presence of the major gastric cell lineages and a polarized epithelium.
In particular, we and others [25] report that the hFGO culture system represents a vital new
technique for modeling H. pylori infection within the normal human tissue in vitro. As re-
ported in similar mouse- and human-derived gastric organoid cultures [22,24,29], our study
takes advantage of the presence of a defined lumen in these models, allowing us to inject live
H. pylori directly into the gastric organoid and assay the epithelial response without the influ-
ence of host recruited factors. This contribution is significant because it provides knowledge re-
quired to potentially develop techniques to disrupt bacterial colonization and prevent disease
progression. Our study helps to uncover a potential mechanism ofH. pylori-induced prolifera-
tion in rodent and human tissue, using both in vivo established models of H. pylori infection
and gastric cancer, as well as a novel epithelial cell culture system.
Materials and Methods
Ethics Statement
All mouse studies were approved by the University of Cincinnati Institutional Animal Care
and Use Committee (IACUC) that maintains an American Association of Assessment and Ac-
creditation of Laboratory Animal Care (AAALAC) facility. Human fundus was collected dur-
ing sleeve gastrectomies (IRB protocol number: 2013–2251).
H. pylori culture
Helicobacter pylori (H. pylori) strain LSH100, a descendant of the clinical isolate G27 [30],
G27 wild type [31] (CagA+), a mutant G27 strain bearing a cagA deletion (ΔcagA::cat) [45] and
H. pylori 7.13 strain were grown on blood agar plates containing Columbia Agar Base (Fisher
Scientific), 5% horse blood (Colorado Serum Company), 5 µg/ml vancomycin and 10 µg/ml tri-
methoprim as previously described [46]. Plates were incubated for 2–3 days at 37°C in a hu-
midified microaerophilic chamber [47].
H. pylori animal inoculations
Bacteria were harvested and resuspended in filtered Brucella broth (BD biosciences) supple-
mented with 10% fetal calf serum. After 12 hours of growth at 37°C in a humidified microaero-
philic chamber, bacteria were harvested, resuspended in filtered Brucella broth and C57/BL6
mice (The Jackson Laboratory, stock number: 000664), B6.129(Cg)-Cd44tm1Hbg/J (CD44-
defiecient) mice (The Jackson Laboratory, stock number stock number: 005085) or Mongolian
gerbils (Charles River) were inoculated by oral gavage with 108 bacteria per 200 µl of Brucella
broth. Mice were infected with either G27 wild type or a mutant G27 strain bearing a cagA de-
letion (ΔcagA::cat). Mongolian gerbils were inoculated withH. pylori strain 7.13. Uninfected
control mice were administered 200 µl of Brucella broth. Mice were analyzed 4 weeks post-
inoculation. Mongolian gerbils were analyzed 6 weeks post-inoculation.
H. pylori colonization was quantified using the culture method previously published [47].
Briefly, the wet weight of gastric tissue collected from uninfected and infected animals was
measured. Tissue was homogenized in 1 ml saline and diluted 1/100 and spread on blood agar
plates containing Campylobacter Base Agar (Fischer Scientific), 5% horse blood (BD Diagnostic
Systems), 5µg/ml vancomycin and 10µg/ml trimethoprim. Plates were incubated for 7–10 days
at 37oC in a humidified microaerophilic chamber. Single colonies from these plates tested
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positive for urease (BD Diagnostic Systems), catalase (using 3% H2O2) and oxidase (DrySlide,
BD Diagnostic Systems). Colonies were counted and data normalized using the tissue wet
weight and expressed and colony forming units (CFU)/g tissue.
Hyaluronan (HA) blocking peptide
Specific hyaluronan (HA) blocking peptide Pep 1 (NH2-GAHHWQFNALTVRGGGS-
CONH2) and scrambled control (NH2-WRHGFALTAVNQGGGS-CONH2) [48] peptides
were synthesized by Pierce Biotechnology (Thermo Scientific-3747, Rockford, IL). Pep1 and
control peptides were administered by intraperitoneal injection to Mongolian gerbils at a con-
centration of 10 mg/kg of body weight three times a week for 6 weeks after H. pylori infection.
Histological scoring
Mongolian Gerbils were euthanized 6 weeks post-infection, stomachs were divided longitudi-
nally for representative sections from both sides of the tissue and stained for Hematoxylin &
Eosin (H&E). H&E stains were analyzed by using the updated Sydney classification system for
histological scoring of gastritis [49].
Immunohistochemical staining
Mice and Mongolian gerbils were injected with BrdU (300 mg/kg) 24 hours prior to analysis.
Stomach sections spanning both the fundic and antral regions collected from experimental ani-
mals were fixed for 16 hours in Carnoy’s Fixative, paraffin embedded and sectioned at 5 µM.
Prepared slides were deparaffinized with antigen retrieval performed by submerging in boiling
solution (1:100 dilution Antigen Unmasking Solution in dH2O, Vector Laboratories, H-3300)
for 10 minutes followed by 20 minutes at room temperature. Sections were then blocked with
5% BSA/PBS for 20 minutes at room temperature. BrdU color development was performed ac-
cording to manufacturer’s protocol (Roche, Cat. No. 11 296 736 001). Immunohistochemical
slides were dehydrated and mounted using Permount and images viewed and captured under
light microscopy (Olympus BX60 with Diagnostic Instruments “Spot” Camera).
Development and culture of mouse-derived fundic gastric organoids
(mFGOs)
Gastric fundic organoids were prepared based on our recently reported protocol [22,50]. Pri-
mary epithelial cells from adult stomach tissue were cultured as 3-dimensional structures called
mouse-derived fundic gastric organoids (mFGOs). Stomachs were dissected from mice along
the greater curvature and washed in ice-cold Ca2+/Mg2+-free Dulbecco’s Phosphate Buffered
Saline (DPBS). The stomach was stripped from muscle and visible blood vessels. Gastric fundus
was further separated and cut into approximately 5 mm2 pieces. Tissue was then incubated in
5 ml of 5 mM EDTA for 2 hours at 4°C with gentle shaking. The EDTA was replaced with 5 ml
chelation buffer (1 g D-sorbital, 1.47 g sucrose in 100 ml DPBS). Next tissue was shaken vigor-
ously for approximately 2 minutes to dissociate glands. Dissociated glands were centrifuged at
150 g for 5 minutes then were embedded inMatrigel (BD Biosciences) supplemented with Ad-
vanced DMEM/F12 medium (Invitrogen), Wnt conditioned medium [22], R-spondin condi-
tioned medium [22] supplemented with gastric growth factors including bone morphogenetic
protein inhibitor, Noggin (PeproTech), Gastrin (Sigma), Epidermal grow factor (EGF, Pepro-
Tech) and Fibroblast growth factor 10 (FGF-10, PeproTech) as previously described [22,50].
Glands grew into organoids by 1–2 days. After 4 days in culture mFGOs were cultured on the
inner well of polyester Transwell inserts (0.4 µm pore size, catalogue number 3460, Corning
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Lifescience), while immortalized stomach mesenchymal cells (ISMCs) were cultured in the
base of the chamber of the Transwell according to our published protocol [22]. Organoids were
co-cultured for a further 3 days prior toH. pylori infection and treatments.
Development and culture of human-derived fundic gastric organoids
(hFGOs)
Human fundic gastric organoids (hFGOs) were generated independently of the recently re-
ported protocol [25]. The fundic mucosa was stripped away from the muscle layer, and then
cut into 5 mm2 pieces and washed 3 times in sterile DPBS without Ca2+ and Mg2+. The mucosa
was transferred to DMEM/F12 (catalogue number 1263–010, Gibco Life Technologies) supple-
mented with 10mMHEPES, 1%Penicillin/Streptomycin and 1X Glutamax, and incubated
while stirring and oxygenated in a 37oC water bath with Collagenase (from Clostridium histoly-
ticum, Sigma C9891, 1 mg/ml) and bovine serum albumin (2 mg/ml) to release glands from the
tissue. After 15–30 minutes of incubation collected glands were washed in sterile phosphate
buffered saline with Kanamycin (50 mg/ml) and Amphotericin B (0.25 mg/ml)/Gentamicin
(10 mg/ml), centrifuged at 200 xg, resuspended in the appropriate volume of Matrigel (50 µl of
Matrigel/well), and subsequently cultured in human gastric organoid media (DMEM/F12 sup-
plemented with 10mMHEPES, 1X Glutamax, 1% Pen/Strep, 1X N2, 1X B27, 1mMN-
Acetylcystine, 10mMNicotidamide, 50ng/mL EGF, 100ng/mL Noggin, 20% R-Spondin Condi-
tioned Media, 50%Wnt Conditioned Media, 200ng/mL FGF10, 1nM Gastrin, 10uM Y-27632,
Kanamycin (50 mg/ml) and Amphotericin B (0.25 mg/ml)/Gentamicin (10 mg/ml)) (Table 1).
Glands grew into organoids by 7 days at which time hFGOs wereH. pylori infected and treated.
We did not observe significant variations in organoid growth between donor gastric glands.
Gastric organoid microinjections and treatments
H. pylori strains G27 and ΔCagA were grown on blood agar plates as described above, and
prior to injection, a group of organoids were pre-treated for one hour with a highly selective,
Table 1. Culture media for human-derived fundic gastric organoids (hFGOs).
Reagent Supplier Cat No. Stock Conc. Final Concentration
Glutmax Invitrogen 35050–079 100X 1X
Penicillin/Streptomycin Invitrogen 15140–122 100X 1X
N2 Supplements Invitrogen 17502–048 100X 1X
B27 Supplements Invitrogen 17504–044 50X 1X
N-Acetylcysteine Sigma-Aldrich A9165–5G 500mM 1mM
Nicotidamide Sigma-Aldrich N0636 1M 10mM
EGF PeproTech AF-100–15 500ug/ml 50ng/ml
Noggin PeproTech 25038 100ug/ml 100ng/ml
FGF10 PeproTech 100–26 100ug/ml 200ng/ml
Gastin1 Tocris 3006 10uM 1nm
Y-27632 Sigma-Aldrich Y0503 10mM 10uM
ADMEM/F12 Invitrogen 12634–010 - 30%
R-spondin Conditioned Media In house 20%
WNT Conditioned Media In house 50%
Amphotericin/Gentamicin Gibco 50–064 100X 1X
Kanamycin A.G. Scientific K-1022 100X 1X
doi:10.1371/journal.ppat.1004663.t001
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high affinity c-Met inhibitor (100 µg/ml, PF04217903 mesylate, Tocris Bioscience Cat.# 4239).
CD44-deficient mouse-derived organoids were treated with Wnt agonist (1µM CALBIO-
CHEM, catalogue number 681665). The hFGOs were pretreated with CD44v6 antibody 1 hour
prior toH. pylori infection at a concentration of 100 ng/ml. Organoids (mFGOs and hFGOs)
cultured for 7 days were injected with 200 nl of Brucella broth using a Nanoject II (Drum-
mond) microinjector, such that each organoid received approximately 2x105 bacteria. Twenty-
four hours after injection, organoids were harvested by washing in ice-cold DPBS to remove
Matrigel, followed by either RNA isolation by TRIzol, protein isolation by M-PER Mammalian
Protein Extraction Reagent (Thermo Scientific, IL) or EdU labeling.
Immunofluorescence
The EdU solution was added to the organoid medium of either mFGOs or hFGOs for uptake
for 1 hour. EdU staining was performed using the Click-iT Alexa Fluor 594 Imaging Kit, ac-
cording to the manufacturer’s instructions (Life Technologies). The mFGOs were fixed with
4% formaldehyde for 20 minutes, followed by permeabilization with 0.5% Triton X-100 in
DPBS for 20 minutes at room temperature. Blocking was done with 2% normal goat serum for
20 minutes at room temperature. The organoids were then incubated at 4oC overnight with an
antibody specific for E-cadherin (Santa Cruz Biotechnology sc-59778, 1:100). Following this,
organoids were incubated with Alexa Fluor 488 again overnight at 4oC. After incubation with
the secondary antibodies organoids were counterstained using nuclear stain (Hoechst 33342,
10 µg/ml, Invitrogen) for 20 minutes at room temperature. Organoids were visualized using
the Zeiss LSM710.
Immunoprecipitation andWestern blot analysis
Both mFGOs and hFGOs were harvested from Matrigel using ice-cold DPBS without Ca2
+/Mg2+ and lysed in M-PER Mammalian Protein Extraction Reagent (Thermo Scientific, IL)
supplemented with protease inhibitors (Roche) according to the manufacturer’s protocol. For
the immunoprecipitation, c-Met antibody (AbCam ab59884) was added to the cell lysates (1:50
dilution) overnight at 4oC. Protein A/G Plus Agarose beads (Santa Cruz sc-2003) were washed
with PSB and added to the cell lysate mixture overnight at 4oC. Cell lysate mixtures were resus-
pended in 40 µl Laemmli Loading Buffer containing eta-mercaptoethanol (Bio-Rad Laborato-
ries, CA) before western blot analysis. Samples were loaded onto 4–12% Tris-Glycine Gradient
Gels (Invitrogen) and run at 80 V, 3.5 hours before transfer to nitrocellulose membranes
(Whatman Protran, 0.45 µM) at 105 V, 1.5 hours at 4oC. Membranes were blocked for 1 hour
at room temperature using KPL Detector Block Solution (Kirkegaard & Perry Laboratories,
Inc.). Membranes were incubated for 16 hours at 4°C with a 1:2000 dilution of either anti-
GAPDH (Millipore, MAB374), 1:100 dilution of anti-phospho Tyrosine (Santa Cruz sc-7020),
anti CagA (Abcam ab90490), anti-CD44 (Abcam ab51037), anti c-Met (Abcam ab59884), or
anti-HGF (Abcam ab83760) followed by a 1 hour incubation with a 1:1000 dilution anti-
mouse or anti-rabbit Alexa Fluor 680 (Invitrogen). Blots were imaged using a scanning densi-
tometer along with analysis software (Odyssey Infrared Imaging Software System).
Quantitative RT-PCR
Total RNA was isolated from mFGOs, hFGOs and gastric glands using TRIzol (Life Technolo-
gies) according to manufacture’s protocol. A High Capacity cDNA Reverse Transcription Kit
synthesized cDNA from 100 ng of RNA following protocol provided by Applied Biosystems.
Real-time PCR assays were utilized for the following genes in the mouse-derived organoids:
GAPDH, alpha-Smooth Muscle Actin (Mm00725412_s1), Zeb1 (Mm00495564_m1) and 2
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(Mm0049713_m1), TWIST 1 (Mm04208233_g1) and 2 (Mm000495564_m1), SNAIL 1
(Mm01249564_g1) and 2 (Mm00441531_m1). Cell lineage markers were determined by RT-
PCR for HK-ATPase (Hs01026288_m1), gastrin (Hs01107047_m1), Muc5ac
(Hs00873651_mH), and Muc6 (Hs01674026_g1). PCR amplifications were done with pre-
validated 20X TaqMan Expression Assay primers, 2X TaqMan Universal Master Mix (Applied
Biosystems), and cDNA template, in a total volume of 20 µL. Amplifications were performed
with duplicate wells in a StepOne Real-Time PCR System (Applied Biosytems), and fold
change was calculated at (Ct-Ct high) = n target, 2ntarget/2nGAPDH = fold change where
Ct = threshold cycle.
Flow cytometric analysis of cell lineages within hFGOs
The hFGOs were washed with cold DPBS without Ca2+/Mg2+ to remove Matrigel, and sus-
pended in 2 ml Accutase (Innovative Cell Technologies, Cat.# AT-104) for 5 minutes at 37°C.
Organoids were broken into single cells using an 18G needle, passed through 20 times. Single
cells were fixed and permeablized using the FIX&PERM Kit from Invitrogen (catalogue num-
ber GAS004), according to manufacturer’s instructions. A first tube of cells was co-stained with
lectin FITC labeled Ulex europaeus (UEAI, Sigma Aldrich), lectin Griffonia simplicifolia Alexa
Fluor 647 (GSII, Molecular Probes) and then rabbit anti-pepsinogen C (Abcam, ab104595) fol-
lowed by an anti-rabbit IgG PE secondary antibody (Abcam, ab7070), all at a 1:100 dilution. A
second tube of cells was co-stained for chromogranin A antibody (Abcam, ab15160) followed
by an anti-rabbit IgG PE conjugated secondary antibody, and anti-HK-ATPase (MA3–923, Af-
finity Bioreagents) followed by an anti-mouse IgG FITC conjugated (Abcam, ab6785), all at a
1:100 dilution. The antibody incubations were done for a period of 20 minutes at room temper-
ature. The stained cells were analyzed using the FACSCalibur flow cytometer (BD Biosciences)
followed by the FloJo software (Tree Star, Ashland, OR).
Statistical analyses
The significance of the results was tested by two-way ANOVA using commercially available
software (GraphPad Prism, GraphPad Software, San Diego, CA). A P value<0.05 was
considered significant.
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